SCHEMBL23514830

SCHEMBL23514830

CC1(O)CCN(CC(F)F)CC1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
CYP2D6 P10635 5/20 0.35
DRD2 P14416 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
SLC6A2 P23975 2/20 0.32
PIK3CD O00329 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12848310 0.80 CYP2D6 (0.47) CYP2D6DRD2ALDH1A1CYP3A4PIK3CD
SCHEMBL23514936 0.79 OPRM1 (0.39) OPRM1OPRD1OPRK1CYP2D6ALDH1A1
SCHEMBL26813264 0.77 OPRM1 (0.35) OPRM1OPRD1OPRK1CYP2D6PIK3CD
SCHEMBL4420326 0.77 CYP2D6 (0.34) CYP2D6DRD2ALDH1A1CYP3A4PIK3CD
SCHEMBL24023540 0.75 CYP2D6 (0.33) CYP2D6DRD2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL12940382 0.75 MAPT (0.57) ALDH1A1PRMT5WDR77
SCHEMBL17176304 0.74 OPRM1 (0.36) OPRM1OPRD1OPRK1CYP2D6ALDH1A1
SCHEMBL3419547 0.74 CYP2D6 (0.42) CYP2D6ALDH1A1CYP3A4PIK3CDSMN1; SMN2
SCHEMBL25001373 0.72 CYP2D6 (0.41) OPRM1OPRD1OPRK1CYP2D6ALDH1A1
SCHEMBL7858206 0.72 KDM4E (0.40) OPRM1OPRD1OPRK1CYP2D6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261777-A1 USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS FOR TREATING CANCER REPARE THERAPEUTICS INC. (CA) 2022-12-22 WO disclosed
WO-2021119523-A1 USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS REPARE THERAPEUTICS INC. (CA) 2021-06-17 WO disclosed